Literature DB >> 12415321

Pathogenesis and prediction of diabetes mellitus: lessons from integrative physiology.

Richard N Bergman1.   

Abstract

The molecular revolution in biology is providing an exponentially increasing body of data regarding subcellular events in normal and pathological conditions. The task of integrating even a small part of this deluge of information is a formidable challenge. Many integrative regulatory principles are still unknown. The present article argues that important principles may be discovered by the repetitive experimental testing of simple isomorphic computer or mathematical models of biological regulation. The system regulating the blood glucose is used as an example. Implicit in a minimal model, postulated more than 20 years ago, were specific but untested assumptions. These assumptions, which were tested over the ensuing decades, have enriched our understanding of metabolic regulation and the causes of diabetes. Currently accepted concepts emerging from modeling include: (a) the importance of sluggish insulin transport across the capillary endothelium in stimulation of glucose uptake; (b) the single gateway concept, that insulin transport across endothelium of adipose tissue suppresses free fatty acids, which act in turn to reduce endogenous glucose production by the liver; (c) the importance of the single gateway mechanism in the metabolic syndrome, whereby increased fat in the abdominal compartment relates to insulin resistance and risk for type 2 diabetes; and (d) the hyperbolic relationship between insulin action and insulin secretion, which provides an accurate prediction of diabetes risk. It is hoped that the experience with the metabolic system will provide a metaphor for other regulatory systems less subjected to critical quantitative analysis. Such analysis may well lead to analogous conceptual understanding of other important integrated biological systems, and provide approaches for early intervention in the pathogenic process of other chronic and devastating diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12415321

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  9 in total

Review 1.  Alterations of glucose metabolism in type 2 diabetes mellitus. An overview.

Authors:  Riccardo C Bonadonna
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

2.  Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans.

Authors:  C Xiao; A Giacca; A Carpentier; G F Lewis
Journal:  Diabetologia       Date:  2006-04-05       Impact factor: 10.122

3.  Dynamics of insulin action in hypertension: assessment from minimal model interpretation of intravenous glucose tolerance test data.

Authors:  Roberto Burattini; Micaela Morettini; Francesco Di Nardo; Massimo Boemi
Journal:  Med Biol Eng Comput       Date:  2011-03-30       Impact factor: 2.602

4.  Enhanced modelling of the glucose–insulin system and its applications in insulin therapies.

Authors:  Haiyan Wang; Jiaxu Li; Yang Kuang
Journal:  J Biol Dyn       Date:  2009-01       Impact factor: 2.179

5.  Systemically modeling the dynamics of plasma insulin in subcutaneous injection of insulin analogues for type 1 diabetes.

Authors:  Jiaxu Li; Yang Kuang
Journal:  Math Biosci Eng       Date:  2009-01       Impact factor: 2.080

Review 6.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 7.  Childhood trauma and personality disorder: toward a biological model.

Authors:  Royce Lee
Journal:  Curr Psychiatry Rep       Date:  2006-02       Impact factor: 5.285

Review 8.  A critical review of mathematical models and data used in diabetology.

Authors:  A Boutayeb; A Chetouani
Journal:  Biomed Eng Online       Date:  2006-06-29       Impact factor: 2.819

9.  Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients.

Authors:  Orfeu M Buxton; Milena K Pavlova; Shawn P O'Connor; Wei Wang; John W Winkelman
Journal:  Nat Sci Sleep       Date:  2017-07-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.